Alessandra Di Filippo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity.

Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity.

Journal: Journal of immunology research

Published: November 10, 2022

Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.

Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.

Journal: International journal of molecular sciences

Published: October 26, 2022

Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile.

Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile.

Journal: Biomedicines

Published: August 21, 2022

Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.

Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.

Journal: Cancer immunology, immunotherapy : CII

Published: July 16, 2022

The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy.

The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy.

Journal: Frontiers in immunology

Published: June 20, 2022

Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study.

Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study.

Journal: Human vaccines & immunotherapeutics

Published: March 08, 2022

Immune effects of CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: Relief from immunosuppression is associated with clinical response.

Immune effects of CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: Relief from immunosuppression is associated with clinical response.

Journal: EBioMedicine

Published: November 23, 2021

Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer.

Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 15, 2021

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib.

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib.

Journal: Frontiers in oncology

Published: August 08, 2021

The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study.

The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study.

Journal: Journal of personalized medicine

Published: May 18, 2021

Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients.

Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients.

Journal: Journal of personalized medicine

Published: October 05, 2020

Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma.

Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma.

Journal: Cancers

Published: August 07, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026